---
figid: PMC8296701__12935_2021_2091_Fig1_HTML
figtitle: Genistein as a regulator of signaling pathways and microRNAs in different
  types of cancers
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8296701
filename: 12935_2021_2091_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8296701/figure/Fig1/
number: F1
caption: Regulatory role of genistein in cellular pathways. Genistein modulates receptor
  tyrosine kinase (RTKs) signal transduction. It prevents the activation of nuclear
  factor kappa-light-chain-enhancer of activated B cells (NF-κB) explicitly either
  by the Akt pathway, Notch pathway, or by P53. It modulates the cell cycle by inhibiting
  cell cycle kinases and up-regulating Cyclin-Dependent Kinase inhibitors (CDKIs).
  It regulates ataxia telangiectasia mutated/F-box protein (ATM/AFR) through p53.
  Genistein also modulates metabolic pathways such as gluconeogenesis via the mTOR
  pathway. It up-regulates the Wnt pathway inhibitors and suppresses signal transduction
  by the Wnt pathway by inhibiting frizzled receptor and low density lipoprotein receptor-related
  protein (LPR) interactions and reduces β-catenin (B-cat) cytoplasmic accumulation.
  Genistein in the figure is depicted by “G’
papertitle: Genistein as a regulator of signaling pathways and microRNAs in different
  types of cancers.
reftext: Zeeshan Javed, et al. Cancer Cell Int. 2021;21:388.
year: '2021'
doi: 10.1186/s12935-021-02091-8
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central
keywords: Genistein | miRNAs | Nano-formulations | Signaling pathways | Therapeutics
automl_pathway: 0.9574305
figid_alias: PMC8296701__F1
figtype: Figure
redirect_from: /figures/PMC8296701__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8296701__12935_2021_2091_Fig1_HTML.html
  '@type': Dataset
  description: Regulatory role of genistein in cellular pathways. Genistein modulates
    receptor tyrosine kinase (RTKs) signal transduction. It prevents the activation
    of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) explicitly
    either by the Akt pathway, Notch pathway, or by P53. It modulates the cell cycle
    by inhibiting cell cycle kinases and up-regulating Cyclin-Dependent Kinase inhibitors
    (CDKIs). It regulates ataxia telangiectasia mutated/F-box protein (ATM/AFR) through
    p53. Genistein also modulates metabolic pathways such as gluconeogenesis via the
    mTOR pathway. It up-regulates the Wnt pathway inhibitors and suppresses signal
    transduction by the Wnt pathway by inhibiting frizzled receptor and low density
    lipoprotein receptor-related protein (LPR) interactions and reduces β-catenin
    (B-cat) cytoplasmic accumulation. Genistein in the figure is depicted by “G’
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - shg
  - .na.character
  - p53
  - betaTub60D
  - hth
  - tefu
  - Egfr
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Dif
  - dl
  - Rel
  - Mtor
  - Tor
  - Tie
  - Ras85D
  - InR
  - Sos
  - grb
  - kra
  - kraken
  - Myd88
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Liprin-alpha
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - dsh
  - arm
  - CDH1
  - STAT3
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - TP53
  - TP63
  - TP73
  - ATM
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - MTOR
  - IL6
  - BAG4
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTG1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - SFRP2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ADAR
  - DVL1P1
---
